Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Descemet Endothelial Thickness Comparison Trial
NCT02373137Phase 4Unknown
- Sponsor
- Oregon Health & Science University
- Start
- Jan 2015
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
Phase 4, randomised trial in Fuchs endothelial dystrophy (FED) and pseudophakic bullous keratopathy (PBK) (2 arms), sponsored by Oregon Health & Science University. Primary endpoint: Best Spectacle-Corrected Visual Acuity at 6 months. Status: unknown.
02
Conditions
Fuchs endothelial dystrophy (FED)pseudophakic bullous keratopathy (PBK)
Beyond the preview
Go deeper on NCT02373137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02373137.